Retrospective outcome data for hematopoietic stem cell transplantation in patients with concurrent coronary artery disease.
暂无分享,去创建一个
R. Steingart | Wendy L. Schaffer | A. Jakubowski | J. Wessler | B. Rebolledo | Elizabeth E. Stillwell | Erica Petrlik
[1] U. Popat,et al. Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] M. Perales,et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. , 2007, Blood.
[3] L. Mileshkin,et al. Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older , 2005, Leukemia & lymphoma.
[4] L. Rybicki,et al. Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction? , 2004, Bone Marrow Transplantation.
[5] S. Singhal,et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over , 2000, Bone Marrow Transplantation.